0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

NERVE GASES

JAMA. 1961;178(7):755-756. doi:10.1001/jama.1961.03040460063015.
Text Size: A A A
Published online

Today the organic phosphorus compounds are among the more commonly encountered poisons. These materials are used widely as insecticides, and they also find application as therapeutic agents in the treatment of myasthenia gravis and glaucoma. This group of compounds contains some of the most toxic agents known, the so-called "nerve gases." The principal, if not the only, pharmacologic effect of the organic phosphorus compounds is inhibition of the enzyme cholinesterase.

Atropine has long been the antidote of choice in treating anticholinesterase poisoning. However, the effect of atropine is limited to pharmacologic antagonism of the excess acetylcholine accumulated as a result of the decreased cholinesterase activity. In recent years antidotes of a new type have been reported. These antidotes are oximes, and they function by regenerating active cholinesterase from the inhibited enzyme complex.

In April, 1958 (p. 1834), The Journal published a report of early Japanese clinical experience in the treatment

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();